Trial NCT03349346

View at ClinicalTrials.gov 
Org. Study IDs: GS-US-313-1090
Secondary IDs: 2017-001468-39

Last trial update was posted on 2018-12-11

MeSH Interventions

Carboplatin Etoposide Idelalisib Ifosfamide Rituximab

MeSH Conditions

Lymphoma Lymphoma, B-Cell Lymphoma, Large B-Cell, Diffuse

Other Conditions

Diffuse Large B-Cell Lymphoma Mediastinal B-cell Lymphoma

Stopping Reasons

The European Medical Agency granted a Paediatric Investigational Product-specific waiver on the grounds that idelalisib is likely to be unsafe in paediatrics

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID